Londini, myers, CHECKMATE-76K, FDA, melanoma, Mirabilis
Nivolumab ab FDA approbatur ad adjuvant tractationem theatri IIB/C melanoma
Nov 2023: Nivolumab (Opdivo, Bristol-Myers Squibb Company) was granted approval by the Food and Drug Administration as an adjuvant therapy for Stage IIB/C melanoma in patients 12 years of age and older who had undergone complete..
BMS, Londini myers, immunotherapy, metastatic melanoma, nivolumab et relatlimab, nivolumab et relatlimab-rmbw, Opdualag, USFDA
Primum LAG-3-obturans compositionem anticorporis, Opdualag™ (nivolumab et relatlimab-rmbw), approbatur a FDA patientibus melanomatis irresectabili vel metastatico
Aprilis 2022: Cibus US et Administration medicamentum (FDA) probavit Opdualag (nivolumab et relatlimab-rmbw), novum, primo-in-genus fixum-dosis compositum ex nivolumab et relatlimab administratum ut infusione unius intravenae, f.
Immunocore Press, Kimmtrak, metastatic uveae melanoma, tebentafusp-tebn, uveae melanoma
Tebentafusp-tebn approbatur pro unresectabili vel metastatico uveali melanoma
Martii 2022 : Tebentafusp-tebn (Kimmtrak, Immunocore Limited), gp100 peptide-HLA directa, CD3 T cellulam bispecialis congressus, a Cibus et medicamentis administrationis licentiatus est ad HLA-A*02:01 adultos aegros cum nonsectab. .
CD-38, FDA, HORIZON, agente immunomodulatory, melphalan flufenamide, multa myeloma, NCT02963493, AB Oncopeptides, Pepaxto
Durum aut de portu FDA probata Melphalan flufenamide multiplex myeloma
August MMXXI: Melphalan flufenamide (Pepaxto, Oncopeptides AB) tandem coniunctim afficient vniuersa dexamethasone cum approbatione datum est accelerated per Cibus et medicamentis Administration pro aegris cum portu et verterunt plures myel adult ..
KEYTRUDA, Merck Poland, NCT02362594, Pembrolizumab, RECIST, USFDA
Probatus per FDA in adjuvant curatio Pembrolizumab est melanoma
Die 15 Februarii 2019, pembrolizumab (KEYTRUDA, Merck) a Cibus et medicamentis Administration probatus est ad curationem aegrorum melanomati adiuvantis cum implicatione nodi lymphae (s) post plenam resectionem. Approbatio..
bariatric surgery, Dellium, India, USA
Bariatric surgery redigendum periculo melanoma
Celeri pondus damnum praeter earn sibi perpetuamque et alia salutem beneficia, bariatric surgery Nunc consociata cum periculo reducitur LXI% malignorum melanoma, quae gravissima est, cutis cancer nimium familiaris fuisse maxime s ..